Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Wegovys active ingredient, semaglutide, works by mimicking the natural hormone GLP-1, which is crucial for regulating appetite, blood sugar levels, and insulin release
If youre dealing with prediabetes or type 2 diabetes, semaglutide helps to regulate blood sugar levels and reduce insulin resistance
A., Moussa, Z., Mughal, E
GLP-1 Timeline: From Diabetes to Pediatric Weight Management 2005: First GLP-1 medications approved for Type 2 diabetes in adults 2014: FDA approves Saxenda (liraglutide) as the first GLP-1 for weight loss 2022: Wegovy approved for adolescents 12 and older 2023: American Academy of Pediatrics endorses GLP-1s for pediatric obesity 2025: FDA considering approval for children as young as 6 years old Though the FDA approved Saxenda as the first GLP-1 for weight loss back in 2014, it wasnt until the last few years that the popularity and availability of these medications for obesity have skyrocketed
US$ 21.32
US$ 20.25
US$ 29.43
